Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia| Listen on Anghami

Jul 1

Paolo Strati on off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy for patients with relapsed or refractory B-cell lymphoma

Associate Professor Paolo Strati (Department of Lymphoma and Myeloma, and Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA) joins us to discuss the results of a multicentre, open-label, phase 1 clinical trial of off- ... Show More

21m 49s

Jun 13

A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies

With a growing number of treatment options for blood cancers, understanding the side effects from these treatments and how they affect patients is becoming ever more important. Join a panel of authors from The Lancet Haematology's latest series on Adverse Event reporting to discu ... Show More

40m 11s

Apr 28

Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma

Dr Michael Northend (University College London Hospitals NHS Foundation Trust, and Cancer Research UK & UCL Cancer Trials Centre, London, UK) joins us to discuss the long-term results of a randomised, phase 3 trial on early rituximab monotherapy versus watchful waiting for advanc ... Show More

15m 49s

Jul 2023

S2 Episode 2: Is It Lupus Nephritis? A Path to Diagnosis and Treatment

Join experts Drs Matt Sparks and Dawn Caster as they discuss the complexities around the management of lupus nephritis. What tools do we have now? What is on the horizon? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape (https://www.m ... Show More

24m 26s

Sep 2023

S2 Episode 4: Chronic Kidney Disease: FSGS, Genetic Testing, and APOL1

Join Drs Matthew Sparks and Kirk Campbell as they dive into the murky waters of focal segmental glomerular sclerosis. How do you diagnose? How do you treat? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/vi ... Show More

27m 55s

Jul 2023

New Treatment for IDH mt Gliomas

Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas. Read the related article in The New England Journal of Medicine. Visit NPUb.org/Podcast for associate ... Show More

18m 19s

May 2024

Long-Term Follow-Up of the LEAP Study

Dr. Vikram Karnik and Dr. Rob de Bie discuss early vs. delayed start of Levodopa in early Parkinson disease, and what it means for our clinical practice. Show reference: https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.29796 This podcast is sponsored by arg ... Show More

1m 51s

May 2024

Lymphatic System Interventions MLD

Which of the following techniques is MOST indicated for manual lymph drainage in the treatment of lymphedema? Find it all out in the podcast! Be prepared for the NPTE so that you can pass with flying colors! Check out www.ptfinalexam.com/podcast for more information and to stay ... Show More

8m 13s

Oct 2021

Why Our Neglected Lymph System Is A Key To Optimal Health with Dr. Mehmet Oz and Dr. Gerald Lemole

This episode is brought to you by Rupa Health, BiOptimizers, and InsideTracker. The lymphatic system is a critically foundational system in helping us feel well and age better. It’s actually part of both our circulatory and immune systems, responsible for fluid regulation, cellul ... Show More

1h 12m

Jul 2023

Dual Antiplatelet Therapy vs Alteplase for Patients With Acute Ischemic Stroke

Dr. Dan Ackerman talks with Dr. Thanh Nguyen about whether dual antiplatelet therapy is noninferior to intravenous thrombolysis among patients with minor nondisabling acute ischemic stroke. Read the related article in JAMA. Visit NPUb.org/Podcast for associated article links. Thi ... Show More

22m 24s

Jan 2024

221. Red Pulp, White Pulp - An approach to splenomegaly

Send us a textIn this episode, we review the physiology and pathophysiology, etiology, clinical exam, investigations and treatment in patients with splenomegaly. Our medicine minute addresses the COMFORT II trial published in the New England Journal of Medicine in 2012. Written ... Show More

12m 14s

Aug 2022

S1 Episode 1: Chronic Kidney Disease and SGLT2 Inhibitors: Usage, Monitoring, and Possible Side Effects

Drs Sparks and Neuen discuss the proper use of SGLT2 inhibitors to prevent chronic kidney disease, including how to start them and monitor them and their possible side effects. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/vie ... Show More

24m 28s

Jacob D Soumerai and Andrew D Zelenetz o...